| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | EVP, Global Research And CSO
1 company
Altshuler David is an EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $10.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 22, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sale+OE | 3,669 | $194.37 | $713,143.53 | -10.4% | |
| Aug 19, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sale+OE | 12,501 | $186.38 | $2,329,976.37 | -7.2% | |
| May 15, 2019 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 91 | $165.41 | $15,052.31 | -0.3% |